Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000641739 | SCV000763387 | uncertain significance | Congenital myasthenic syndrome 4A | 2021-09-07 | criteria provided, single submitter | clinical testing | This sequence change replaces threonine with arginine at codon 170 of the CHRNE protein (p.Thr170Arg). The threonine residue is highly conserved and there is a moderate physicochemical difference between threonine and arginine. This variant is present in population databases (rs375652301, ExAC 0.006%). This variant has not been reported in the literature in individuals affected with CHRNE-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
MGZ Medical Genetics Center | RCV000641739 | SCV002580522 | uncertain significance | Congenital myasthenic syndrome 4A | 2021-09-28 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV003144416 | SCV003833690 | uncertain significance | not provided | 2019-05-01 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001835038 | SCV002093427 | uncertain significance | Congenital myasthenic syndrome | 2019-10-28 | no assertion criteria provided | clinical testing |